Skip to main content

Advertisement

Log in

Role of platelet glycoprotein polymorphisms in cardiovascular diseases

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Atherothrombosis is the leading cause of death in western countries. Major complications of atherothrombotic disease, which are responsible for a large burden of morbidity and mortality, are acute coronary syndromes, ischemic stroke, and peripheral occlusive disease. Plaque rupture, platelet adhesion, aggregation, and thrombosis may lead to unstable angina and may progress to myocardial infarction as well as to ischemic stroke. Platelet membrane glycoprotein receptors mediate crucial reactions in acute thrombosis and chronic processes of atherogenesis. The platelet glycoprotein GP IIb/IIIa, which is the most abundant platelet receptor, also represents the drug target of a novel class of anti-platelet drugs, which includes abciximab, tirofiban, and eptifibatide. The genes encoding the three major platelet glycoprotein receptors (GP Ib/IX/V, GP Ia/IIa, and GP IIb/IIIa) are subject to considerable genetic variability. This paper reviews how polymorphisms in the platelet glycoprotein receptors affect platelet function, susceptibility to atherothrombosis and its major complications including myocardial infarction, stroke, and complications following percutaneous coronary interventions, and individual variability of drug response. Recent data on platelet glycoprotein receptor polymorphisms as modifiers of drug action and as predictors of drug response offer the perspective of individualized drug treatment. Prospective studies will show whether this approach is useful or not. As the data reviewed here show clearly, future clinical trials should routinely take into account genetic susceptibility factors and modifiers, both for study design and for predefined patient stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ACS:

Acute coronary syndrome

CI:

Confidence interval

DCA:

Directional coronary atherectomy

GP:

Glycoprotein

MACE:

Major adverse cardiac event

MI:

Myocardial infarction

PCI:

Percutaneous coronary intervention

PTCA:

Percutaneous transluminal coronary angioplasty

RR:

Relative risk

SCD:

Sudden cardiac death

VWF:

Von Willebrand factor

References

  • Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82:524–525

    Article  CAS  PubMed  Google Scholar 

  • Afshar Kharghan V, Li CQ, Khoshnevis Asl M, Lopez JA (1999) Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186–191

    CAS  PubMed  Google Scholar 

  • Aleksic N, Juneja H, Folsom AR, Ahn C, Boerwinkle E, Chambless LE, Wu KK (2000) Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 102:1901–1905

    Google Scholar 

  • Anderson JL, King GJ, Bair RL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF (1999) Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 33:727–733

    Article  CAS  PubMed  Google Scholar 

  • Andrews R, Shen Y, Gardiner E, Dong J, Lopez J, Berndt M (1999) The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 82:357–364

    CAS  PubMed  Google Scholar 

  • Andrioli G, Minuz P, Solero P, Pincelli S, Ortolani R, Lussignoli S, Bellavite P (2000) Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol 110:911–918

    Article  CAS  PubMed  Google Scholar 

  • Ardissino D, Mannucci, PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94:46–51

    CAS  PubMed  Google Scholar 

  • Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122

    PubMed  Google Scholar 

  • Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G (2001) Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98:36–40

    Article  CAS  PubMed  Google Scholar 

  • Benze G, Heinrich J, Schulte H, Rust S, Nowak-Gottl U, Tataru MC, Kohler E, Assmann G, Junker R (2002) Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 23:325–330

    Article  CAS  PubMed  Google Scholar 

  • Boden WE, McKay RG (2001) Optimal treatment of acute coronary syndromes—an evolving strategy. N Engl J Med 344:1939–1942

    Article  CAS  PubMed  Google Scholar 

  • Bottiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schomig K, von Beckerath N, Schomig A (2000) HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83:559–562

    CAS  PubMed  Google Scholar 

  • Boudoulas KD, Cooke GE, Roos CM, Bay PF, Goldschmidt-Clermont (2001) The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 125:112–115

    CAS  PubMed  Google Scholar 

  • Bray PF, Barsh G, Rosa JP, Luo XY, Magenis E, Shuman MA (1988) Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 85:8683–8687

    CAS  PubMed  Google Scholar 

  • Cadroy Y, Sakariassen KS, Charlet JP, Thalamas C, Boneu B, Sie P (2001) Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 98:3159–3161

    Article  CAS  PubMed  Google Scholar 

  • Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A (1999) The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93:3583–3586

    CAS  PubMed  Google Scholar 

  • Carter AM, Ossei-Gerning G, Grant PJ (1996) Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet 348:485–486

    CAS  Google Scholar 

  • Carter AM, Catto AJ, Bamford JM, Grant PJ (1998) Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 18:1124–1131

    Google Scholar 

  • Casorelli I, De Stefano V, Leone AM, Chiusolo P, Burzotta F, Paciaroni K, Rossi E, Andreotti F, Leone G, Maseri A (2001) The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol 114:150–15

    Article  CAS  PubMed  Google Scholar 

  • Coller BS (1995) Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 92:2373–2380

    CAS  PubMed  Google Scholar 

  • Coller BS (1997) Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 99:1467–1471

    CAS  PubMed  Google Scholar 

  • Corral J, Gonzalez-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V (1997) HPA-1 genotype in arterial thrombosis—role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 8:284–290

    CAS  PubMed  Google Scholar 

  • Corral J, Lozano ML, Gonzalez-Conejero R, Martinez C, Iniesta JA, Rivera J, Vicente V (2000) A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 83:23–28

    CAS  PubMed  Google Scholar 

  • Croft SA, Hampton KK, Sorrell JA, Steeds RP, Channer KS, Samani NJ, Daly ME (1999) The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol 106:771–776

    Article  CAS  PubMed  Google Scholar 

  • Di Paola J, Federici AB, Mannucci PM, Canciani MT, Krtizik M, Kunicki TJ, Nugent D (1999) Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93:3578–3582

    PubMed  Google Scholar 

  • Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ, Tuddenham EG (2002) Platelet membrane glycoprotein Ibalpha gene—5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 87:70–74

    Article  CAS  PubMed  Google Scholar 

  • Durante-Mangoni E, Davies GJ, Ahmed N, Ruggiero G, Tuddenham EG (1998) Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism. Thromb Haemost 80:218–219

    CAS  PubMed  Google Scholar 

  • Feng D, Lindpaintner K, Larson MG, Rao VS, O’Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz, D’Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19:1142–1147

    CAS  PubMed  Google Scholar 

  • Feng D, Lindpaintner K, Larson MG, O’Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D’Agostino RB, Levy D, Tofler GH (2001) Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: the Framingham Heart Study. Circulation 104:140–144

    CAS  PubMed  Google Scholar 

  • Frederickson BJ, Dong JF, McIntire LV, Lopez JA (1998) Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 92:3684–3693

    PubMed  Google Scholar 

  • French DL, Seligsohn U (2000) Platelet glycoprotein IIb/IIIa receptors and Glanzmann’s thrombasthenia. Arterioscler Thromb Vasc Biol 20:607–610

    CAS  PubMed  Google Scholar 

  • Furihata K, Nugent DJ, Kunicki TJ (2002) Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis. Arch Pathol Lab Med 126:305–309

    CAS  PubMed  Google Scholar 

  • Garcia-Ribes M, Gonzalez-Lamuno D, Hernandez-Estefania R, Colman T, Pocovi M, Delgado-Rodriguez M, Garcia-Fuentes M, Revuelta JM (1998) Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost 79:1126–1129

    CAS  PubMed  Google Scholar 

  • Gardemann A, Humme J, Stricker J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W (1998) Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 80:214–217

    CAS  PubMed  Google Scholar 

  • George JN, Caen JP, Nurden AT (1990) Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood 75:1383–1395

    PubMed  Google Scholar 

  • Gonzalez Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V (1998) Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 92:2771–2776

    CAS  PubMed  Google Scholar 

  • Goodall AH, Curzen N, Panesar M, Hurd C, Knight CJ, Ouwehand WH, Fox KM (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20:742–747

    Article  CAS  PubMed  Google Scholar 

  • Hato T, Minamoto Y, Fukuyama T, Fujita S (1997) Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 80:1222–1224

    Article  CAS  PubMed  Google Scholar 

  • Hermann SM, Poirier O, Marques-Vidal P, Evans A, Arveiler D, Luc G, Emmerich J, Cambien F (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l’Infarctus du Myocarde. Thromb Haemost 77:1179–1181

    PubMed  Google Scholar 

  • Ioannidis JP, Ntzani EE, Trikanlinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306–309

    Article  CAS  PubMed  Google Scholar 

  • Ishida F, Furihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, Furuta S (1995) The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Blood 86:1357–1360

    CAS  PubMed  Google Scholar 

  • Ishida F, Ito T, Takei M, Shimodaira S, Kitano K, Kiyosawa K (2000) Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 111:1247–1249

    Article  CAS  PubMed  Google Scholar 

  • Ito T, Ishida F, Shimodaira, Kitano K (1999) Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease. Int J Hematol 70:47–51

    CAS  PubMed  Google Scholar 

  • Jacquelin B, Tarantino MD, Kritzik M, Rozenshteyn D, Koziol JA, Nurden AT, Kunicki TJ (2001) Allele-dependent transcriptional regulation of the human integrin alpha2 gene. Blood 97:1721–1726

    Article  CAS  PubMed  Google Scholar 

  • Jilma-Stohlawetz P, Homoncik M, Jilma B, Knechtelsdorfer M, Unger P, Mannhalter C, Santoso S, Panzer S (2003) Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 120:652–655

    Article  CAS  PubMed  Google Scholar 

  • Kaiser R, Tremblay PB, Roots I, Brockmoller J (2002) Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35:49–56

    Article  CAS  PubMed  Google Scholar 

  • Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ (2002) Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32:643–648

    Article  CAS  PubMed  Google Scholar 

  • Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt (1994) Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing. Thromb Haemost 71:651–654

    CAS  PubMed  Google Scholar 

  • Kastrati A, Schomig A, Seyfarth M, Koch W, Elezi S, Bottiger C, Mehilli J, Schomig K, von Beckerath N (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99:1005–1010

    CAS  PubMed  Google Scholar 

  • Kastrati A, Koch W, Gawaz M, Mehilli J, Bottiger C, Schomig K, von Beckerath N, Schomig A (2000) PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol 36:84–89

    Article  CAS  PubMed  Google Scholar 

  • Kekomäki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, Kontula K (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 6:13–17

    PubMed  Google Scholar 

  • Kenny D, Muckian C, Fitzgerald DJ, Cannon CP, Shields DC (2002) Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 13:13–19

    Article  CAS  PubMed  Google Scholar 

  • Kozak M (1981) Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res 9:5233–5262

    CAS  PubMed  Google Scholar 

  • Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ (1998) Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92:2382–2388

    CAS  PubMed  Google Scholar 

  • Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S (2000) The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 83:392–396

    CAS  PubMed  Google Scholar 

  • Kuijpers RW, Faber NM, Cuypers HT, Ouwehand WH, von dem Borne AE (1992a) NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 89:381–384

    CAS  PubMed  Google Scholar 

  • Kuijpers RW, Ouwehand WH, Bleeker PM, Christie D, von dem Borne AE (1992b) Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 79:283–288

    CAS  PubMed  Google Scholar 

  • Kunicki TJ (2002) The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 22:14–20

    Article  CAS  PubMed  Google Scholar 

  • Kunicki TJ, Orchekowski R, Annis D, Honda Y (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82:2693–2703

    CAS  PubMed  Google Scholar 

  • Kunicki TJ, Kritzik M, Annis DS, Nugent DJ (1997) Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89:1939–1943

    CAS  PubMed  Google Scholar 

  • Lanza F, Kieffer N, Phillips DR, Fitzgerald LA (1990) Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta-subunit gene. J Biol Chem 265:18098–18103

    CAS  PubMed  Google Scholar 

  • Laule M, Cascorbi I, Stangl V, Bielecke C, Wernecke KD, Mrozikiewicz PM, Felix SB, Roots I, Baumann G, Stangl K (1999) A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 253:708–712

    Article  Google Scholar 

  • Li CQ, Garner SF, Davies J, Smethurst PA, Wardell MR, Ouwehand WH (2000) Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 95:205–211

    CAS  PubMed  Google Scholar 

  • Lopez JA, Dong JF (1997) Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 4:323–329

    CAS  PubMed  Google Scholar 

  • Lopez JA, Ludwig EH, McCarthy BJ (1992) Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 267:10055–10061

    CAS  PubMed  Google Scholar 

  • Lopez JA, Andrews RK, Afshar Kharghan V, Berndt MC (1998) Bernard-Soulier syndrome. Blood 91:4397–4418

    CAS  PubMed  Google Scholar 

  • Mamotte CD, van Bockxmeer FM, Taylor RR (1998) PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 82:13–16

    Article  CAS  PubMed  Google Scholar 

  • Marian AJ, Brugada R, Kleiman NS (1996) Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 335:1071–1072; discussion 1073–1074

    Article  CAS  PubMed  Google Scholar 

  • Mazzucato M, Pradella P, de Angelis V, Steffan A, de Marco L (1996) Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Ib alpha in an Italian population. Transfusion 36:891–894

    CAS  PubMed  Google Scholar 

  • Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M (2001) In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 112:621–631

    Article  CAS  PubMed  Google Scholar 

  • Meisel C, Laule M, Cascorbi I, Herrmann A, Stangl V, Roots I, Stangl K (2000a) The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventions. Blood 96:2002–2003

    CAS  Google Scholar 

  • Meisel C, Roots I, Cascorbi I, Brinkmann U, Brockmöller J (2000b) How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport. Clin Chem Lab Med 38:869–876

    CAS  PubMed  Google Scholar 

  • Meisel C, Afshar Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, Baumann, Lopez JA, Roots I, Stangl K (2001) Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 38:1023–1027

    Google Scholar 

  • Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmöller J, Roots I (2003) Implications of pharmacogenetics for individualising drug treatment and for study design. J Mol Med 81:154–167

    PubMed  Google Scholar 

  • Mercier B, Munier S, Berault V, Mansourati J, Blanc JJ, Ferec C (2000) Myocardial infarction: absence of association with VNTR polymorphism of GP Ibalpha. Thromb Haemost 84:921–922

    CAS  PubMed  Google Scholar 

  • Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF (2000) Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 101:1013–1018

    CAS  PubMed  Google Scholar 

  • Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttila A, Karhunen PJ (1999) Glycoprotein IIIa PlA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscl Thromb Vasc Biol 19:2573–2578

    CAS  PubMed  Google Scholar 

  • Mikkelson J, Perola M, Penttila A, Karhunen PJ (2001) Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104:876–880

    CAS  PubMed  Google Scholar 

  • Miller JL (1996) Platelet-type von Willebrand disease. Thromb Haemost 75:865–869

    CAS  PubMed  Google Scholar 

  • Morita H, Kurihara H, Imai Y, Sugiyama T, Hamada C, Sakai E, Mori M, Nagai R (2001) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 85:226–230

    CAS  PubMed  Google Scholar 

  • Moroi M, Jung SM, Yoshida N (1984) Genetic polymorphism of platelet glycoprotein Ib. Blood 64:622–629

    CAS  PubMed  Google Scholar 

  • Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351–354

    Article  CAS  PubMed  Google Scholar 

  • Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM (1992) Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Blood 79:3086–3090

    CAS  PubMed  Google Scholar 

  • Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96:3281–3286

    CAS  PubMed  Google Scholar 

  • Newman PJ (1997) Platelet alloantigens: cardiovascular as well as immunological risk factors? Lancet 349:370–371

    Article  CAS  PubMed  Google Scholar 

  • Newman PJ, Derbes RS, Aster RH (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83:1778–1781

    CAS  PubMed  Google Scholar 

  • Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470–472

    CAS  PubMed  Google Scholar 

  • Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ (1986) Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 68:692–695

    CAS  PubMed  Google Scholar 

  • Nurden AT, Nurden P (2001) Inherited defects of platelet function. Rev Clin Exp Hematol 5:314–334; quiz 431

    Article  CAS  PubMed  Google Scholar 

  • O’Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ (2001) Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 98:3256–3260

    Article  CAS  PubMed  Google Scholar 

  • Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME (1996) Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet 348:1309–1310

    CAS  PubMed  Google Scholar 

  • Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831–843

    CAS  PubMed  Google Scholar 

  • Prandini MH, Denarier E, Frachet P, Uzan G, Marguerie G (1988) Isolation of the human platelet glycoprotein IIb gene and characterization of the 5’ flanking region. Biochem Biophys Res Commun 156:595–601

    CAS  PubMed  Google Scholar 

  • Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628–1633

    CAS  PubMed  Google Scholar 

  • Reiner AP, Siscovick DS, Rosendaal FR (2001) Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol 5:262–287; discussion 311–262

    Article  CAS  PubMed  Google Scholar 

  • Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385–388

    Article  CAS  PubMed  Google Scholar 

  • Roest M, Banga JD, Grobbee DE, de Groot PG, Sixma JJ (2000) Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102:1645–1650

    CAS  PubMed  Google Scholar 

  • Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814

    Article  CAS  PubMed  Google Scholar 

  • Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126

    CAS  PubMed  Google Scholar 

  • Ruan J, Peyruchaud O, Nurden A, Bourre F (1998) Linkage of four polymorphisms on the alphaIIb gene. Br J Haematol 102:622–625

    Article  CAS  PubMed  Google Scholar 

  • Samani NJ, Lodwick D (1997) Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 33:693–697

    Article  CAS  PubMed  Google Scholar 

  • Santoro SA (1999) Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood 93:3575–3577

    CAS  PubMed  Google Scholar 

  • Santoso S, Kalb R, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ (1993) The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2). J Clin Invest 92:2427–2432

    CAS  PubMed  Google Scholar 

  • Santoso S, Amrhein J, Hofmann HA, Sachs UJ, Walka MM, Kroll H, Kiefel V (1999a) A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation. Blood 94:4103–4111

    CAS  PubMed  Google Scholar 

  • Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A (1999b) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in young patients. Blood 93:2449–2453

    CAS  PubMed  Google Scholar 

  • Santoso S, Zimmermann P, Sachs UJ, Gardemann A (2002) The impact of the Kozak sequence polymorphism of the glycoprotein Ib alpha gene on the risk and extent of coronary heart disease. Thromb Haemost 87:345–346

    CAS  PubMed  Google Scholar 

  • Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289–297

    CAS  PubMed  Google Scholar 

  • Scaglione L, Bergerone S, Gaschino G, Imazio M, Maccagnani A, Gambino R, Cassader M, Di Leo M, Macchia G, Brusca A, Pagano G, Cavallo-Perin (1998) Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest 28:385–388

    Article  CAS  PubMed  Google Scholar 

  • Shattil SJ, Kashiwagi H, Pampori N (1998) Integrin signaling: the platelet paradigm. Blood 91:2645–2657

    CAS  PubMed  Google Scholar 

  • Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA (2000) Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193–204

    Article  CAS  PubMed  Google Scholar 

  • Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K (2000) Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke 31:493–497

    CAS  PubMed  Google Scholar 

  • Sonoda A, Murata M, Ikeda Y, Fukuuchi Y, Watanabe K (2001) Stroke and platelet glycoprotein Ibalpha polymorphisms. Thromb Haemost 85:573–574

    CAS  PubMed  Google Scholar 

  • Sperr WR, Huber K, Roden M, Janisiw M, Lang T, Graf S, Maurer G, Mayr WR, Panzer S (1998) Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 90:117–123

    Article  CAS  PubMed  Google Scholar 

  • Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A (2001) Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32:2753–2758

    CAS  PubMed  Google Scholar 

  • Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965–967

    Article  CAS  PubMed  Google Scholar 

  • Tanaka S, Ohnoki S, Shibata H, Okubo Y, Yamaguchi H, Shibata Y (1996) Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese. Transfusion 36:813–817

    CAS  PubMed  Google Scholar 

  • Theodoropoulos I, Christopoulos C, Metcalfe P, Dimitriadou E, Economopoulos P, Loucopoulos D (2001) The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol 114:387–393

    Article  CAS  PubMed  Google Scholar 

  • Thornton MA, Poncz M, Korostishevsky M, Yakobson E, Usher S, Seligsohn U, Peretz H (1999) The human platelet alphaIIb gene is not closely linked to its integrin partner beta3. Blood 94:2039–2047

    CAS  PubMed  Google Scholar 

  • Undas A, Sanak M, Musial J, Szczeklik A (1999) Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet 353:982–983

    Article  CAS  PubMed  Google Scholar 

  • Undas A, Brummel K, Musial J, Mann KG, Szczeklik A (2001) Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104:2666–2672

    CAS  PubMed  Google Scholar 

  • Van Goor ML, Gomez Garcia E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW (2002) PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 108:63–65

    Article  PubMed  Google Scholar 

  • Von Beckerath N, Koch W, Mehilli J, Böttiger C, Schömig A, Kastrati A (2000) Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 95:3297–3301

    PubMed  Google Scholar 

  • Von Beckerath N, Koch W, Mehilli J, Bottiger C, Braun S, Schomig A, Kastrati A (2001) Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. Atherosclerosis 156:463–468

    Article  PubMed  Google Scholar 

  • Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJl, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke 29:581–585

    CAS  PubMed  Google Scholar 

  • Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM (1997) Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350:1217–1219

    CAS  PubMed  Google Scholar 

  • Walter DH, Schachinger V, Elsner M, Mach S, Dimmeler S, Auch-Schwelk W, Zeiher AM (2001) Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene. Eur Heart J 22:587–595

    Article  CAS  PubMed  Google Scholar 

  • Ware J (1998) Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 79:466–478

    CAS  PubMed  Google Scholar 

  • Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090–1094

    CAS  PubMed  Google Scholar 

  • Wheeler GL, Braden GA, Bray PF, Marciniak SJ, Mascelli MA, Sane DC (2002) Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. Am Heart J 143:76–82

    Article  CAS  PubMed  Google Scholar 

  • Zhu MM, Weedon J, Clark LT (2000) Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 86:1000–1005

    Article  CAS  PubMed  Google Scholar 

  • Zotz RB, Winkelmann BR, Nauck M, Giers G, Maruhn-Debowski B, Marz W, Scharf RE (1998) Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79:731–735

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the German Ministry of Education, and Research “Berlin Center for Genome Based Bioinformatics” grant 031U209B the “Lead Project Partnership: Pharmacogenetic Diagnostics” grant 01 GG 9845/5, and a grant from the US National Institutes of Health (Grant RO1 HL65205).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Meisel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meisel, C., López, J.A. & Stangl, K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn-Schmiedeberg's Arch Pharmacol 369, 38–54 (2004). https://doi.org/10.1007/s00210-003-0828-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-003-0828-y

Keywords

Navigation